<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01890499</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00029966</org_study_id>
    <nct_id>NCT01890499</nct_id>
  </id_info>
  <brief_title>Prospective Controlled Trial On Clear Feeds Versus Low Residue Diet After Surgery In Elective Colorectal Surgery Patients</brief_title>
  <official_title>PROSPECTIVE RANDOMIZED CONTROLLED TRIAL ON CLEAR FEEDS VERSUS LOW RESIDUE DIET AFTER SURGERY IN ELECTIVE COLORECTAL SURGERY PATIENTS.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cedars-Sinai Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cedars-Sinai Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective randomized controlled trial investigating commencement of low residue diet versus&#xD;
      clear feeds on postoperative day one following elective colorectal surgery, with regards to&#xD;
      patient tolerability, incidence of nausea and/or vomiting, and postoperative length of&#xD;
      hospitalization stay.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Based on current literature, the incidence of postoperative nausea and vomiting varies widely&#xD;
      and can reach up to 40% in abdominal surgery patients. Thus, patient tolerability to&#xD;
      postoperative enteral feeds is taken as 60%. This is a superiority trial: group one is the&#xD;
      clear feeds group and patient tolerability in this group is taken to be 60%. Group two is the&#xD;
      low residue diet group.&#xD;
&#xD;
      The primary hypothesis is that the incidence of postoperative ileus is not affected by the&#xD;
      consistency of enteral diet given, and patients who are placed on low residue diet from&#xD;
      postoperative day one do not have an increased risk of postoperative nausea and vomiting as&#xD;
      compared to patients who are placed on clear feeds.&#xD;
&#xD;
      The primary endpoint measured is Patient tolerability, as evidenced by development of&#xD;
      vomiting on postoperative day two.&#xD;
&#xD;
      Key Inclusion criteria are:&#xD;
&#xD;
        1. Able to freely give written informed consent to participate in the study and have signed&#xD;
           the Informed Consent Form;&#xD;
&#xD;
        2. Males or females, &gt;18 years of age inclusive at the time of study screening;&#xD;
&#xD;
        3. American Society of Anesthesiologists (ASA) Class I-III;&#xD;
&#xD;
        4. Colorectal surgery (open and/or laparoscopic);&#xD;
&#xD;
        5. Elective Surgery.&#xD;
&#xD;
      Key Exclusion criteria are:&#xD;
&#xD;
        1. Mentally incompetent or unable or unwilling to provide informed consent or comply with&#xD;
           study procedures.&#xD;
&#xD;
        2. Children &lt;18 years of age.&#xD;
&#xD;
        3. Pre-operative clinical diagnosis of intestinal obstruction.&#xD;
&#xD;
        4. Pre-existing known upper gastrointestinal disorders.&#xD;
&#xD;
        5. Pre-existing oropharyngeal disorders such as stomatitis, altered taste sensations.&#xD;
&#xD;
        6. Open upper abdominal surgical incisions.&#xD;
&#xD;
        7. Colorectal surgery with concomitant resectional surgery of the stomach or proximal&#xD;
           jejunum (small bowel).&#xD;
&#xD;
        8. Pregnant patients.&#xD;
&#xD;
        9. Bedbound or moribund patients.&#xD;
&#xD;
       10. Pre-existing history of clinical depression.&#xD;
&#xD;
       11. Epidural analgesia.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2012</start_date>
  <completion_date type="Actual">September 2013</completion_date>
  <primary_completion_date type="Actual">August 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Development of nausea and vomiting on postoperative day two</measure>
    <time_frame>postoperative day two</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">104</enrollment>
  <condition>Nausea/Vomiting</condition>
  <arm_group>
    <arm_group_label>Low residue diet arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Two arm randomized controlled trial. First arm is the Clear feeds on postoperative day one arm.&#xD;
The second arm (interventional arm) is the Low Residue diet on postoperative day one arm.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Clear feeds arm</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard of care is to start clear feeds on postoperative day one for elective colorectal surgery patients.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Low Residue diet arm.</intervention_name>
    <description>Interventional arm is to provide low residue diet on postoperative day one.</description>
    <arm_group_label>Clear feeds arm</arm_group_label>
    <arm_group_label>Low residue diet arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Able to freely give written informed consent to participate in the study and have&#xD;
             signed the Informed Consent Form;&#xD;
&#xD;
          2. Males or females, &gt;18 years of age inclusive at the time of study screening;&#xD;
&#xD;
          3. American Society of Anesthesiologists (ASA) Class I-III;&#xD;
&#xD;
          4. Colorectal surgery (open and/or laparoscopic);&#xD;
&#xD;
          5. Elective Surgery.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Mentally incompetent or unable or unwilling to provide informed consent or comply with&#xD;
             study procedures.&#xD;
&#xD;
          2. Children &lt;18 years of age.&#xD;
&#xD;
          3. Pre-operative clinical diagnosis of intestinal obstruction.&#xD;
&#xD;
          4. Pre-existing known upper gastrointestinal disorders.&#xD;
&#xD;
          5. Pre-existing oropharyngeal disorders such as stomatitis, altered taste sensations.&#xD;
&#xD;
          6. Open upper abdominal surgical incisions.&#xD;
&#xD;
          7. Colorectal surgery with concomitant resectional surgery of the stomach or proximal&#xD;
             jejunum (small bowel).&#xD;
&#xD;
          8. Pregnant patients.&#xD;
&#xD;
          9. Bedbound or moribund patients.&#xD;
&#xD;
         10. Pre-existing history of clinical depression.&#xD;
&#xD;
         11. Epidural analgesia.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>philip R Fleshner, M.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cedars-Sinai Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cedars Sinai Medical Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90048</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2015</verification_date>
  <study_first_submitted>June 27, 2013</study_first_submitted>
  <study_first_submitted_qc>June 28, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 1, 2013</study_first_posted>
  <last_update_submitted>February 2, 2015</last_update_submitted>
  <last_update_submitted_qc>February 2, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 4, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cedars-Sinai Medical Center</investigator_affiliation>
    <investigator_full_name>Phillip Fleshner MD</investigator_full_name>
    <investigator_title>Program Director, Colorectal Surgery Fellowship Shierley, Jesslyne, and Emmeline Widjaja Chair in Colorectal Surgery</investigator_title>
  </responsible_party>
  <keyword>tolerability</keyword>
  <keyword>diet after operation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vomiting</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

